Company registration number= 2977135 Charity registration number: 1049067 Wythenshawe Hospital Transplant Fund (A company limiied by guarantee) Annual Report and Financial Statements for the Year Ended 31 March 2024
Wythenshawe Hospital Transplant Fund Contents Reference and Administrative Details Trustees, Report 2to4 Statement of Trustees, Responsibilities Independent Examinetrs Report Statement of Financial Activities 7t08 Balance Sheet Notes to the Financial Statements IOto20
Wythenshawe Hospital Transplant Fund Reference and Administrative Details Trustees Dr P Callan D K Cornwall N Eadie S Fowler E Mather W Noble R Venkateswaran R Wood MJHill Secretary L C Ellis Charity Registration Number 1049067 Companv Registration Number 2977135 The charity is incorporated in England and Wales. The Transplant Fund Olfice Transplant Centre Wjthenshaii'e H05Pital Manchester M23 9LT Principal orriee Independent Examiner Helen Binns FCA Chartered Accountant Beever and Struthers One Expre55 l George Leigh Street Manche5teT M5 4DL Solieitors: Addleshaw Goddard One St Petevs Square Manchester M2 3DE Bankers HSBC Bank plc I I Stamford New Road Altrincham WA14 IBW W H I land I I St James's Square Manchester M2 6WH Page I
Wythenshawe Hospital Transplant Fund Trustees, Report The trustees, who are directors for the purposes of company law, present the annual report together with the financial statements and auditors, report of the charitable company for the year ended 31 March 2024. Trustees and officers The trustees and officers serving during the year and since the year end were as follows: Trustees: Dr P Callan D K Cornwall N Eadie S Fowler E Mather W Noble R Venkateswaran J Haworth (resigned 6 December 2023) R Wood M J Hill (appointed 7 December 2023) Objectives and activities Objects and ainLS In setting our objectives and planning our activities. the Trustees have given careful consideration to the Charity Commission's general guidance on public benefit. As detennined by the charity's Memorandum and Articles of Association, the principal activity of the charity is to support the programme of heart and lung transplantation at Wythensham'e Hospital. Manchester, serving the North West of England. Whilst the NHS provides substantial funds for the transplant centre there is alwa}'s a demand for state-of-the-art equipment or money to support pioneering treatments and research which the NHS is unwilling to fund. The charity plays a vital role by providing funds to accelerate the adoption of new procedures and by funding research which advances the technolo¥ surrounding transplantation. thus enabling the Wjthenshawe Transplant Centre to remain at the forefront of excellence lor the treatment of cardiac and lung disease. The charity is in regular contact with Wythenshawe H05Pital and receive5 funding requests from the hospital. The Board determine5 whether to meet these requests for funding. The charity doe5 not enter into contractual relationships with suppliers of equipment and service5. It only provide5 the agreed funding. The TSleeS, policy is to approve all major grants prior to commitment of funds. Wilh the exception of minor funding of up to £5,000, which may be approved by the Chairnian, decisions relating to the allocation of funds are reserved to the Board and cannot be delegated. Public benefit All the activities of the charity are undertaken to further public benefit. The trustees confirm that they have complied with the requirements of section 17 of the Charities Act 201 I to have due regard to the public benefit guidance published by the Charity Commission for England and Wales. Page 2
Wythenshawe Hospital Transplant Fund Trustees, Report Aehievements and performanee Voluntary donations, legacies and other trading activities raised a total of £131,556 (2023= £131,443) grant income was £10,000 (2023.. £nil) and investment incorne on our investments and cash deposits generated £29,504 (2023= £24,530). This has allowed the Trustees of the charity to continue the support for requests submitted to it. Achievements this year have included continuing to purchase Sherpa packs for the more efficient transportation of donor hearts, financial support for the Transplant Games participants and equipment for patients use on the Jim Quick Ward. The major refurbishment works M'hich we have planned for the Jim Quick Ward have once again been put on hold. Financial review The results for the year and their impact on the Charity's funds are set out in delail in the Statement of Financial Activities. Total net income for the year was £73:157 (2023- £94,195) and the year-end net assets amounted to £1,508,550 (2023- £1,435,393).. including £1,517,936 (2023.. £1,444,152) in cash at the bank or invested in UK Govemment Stocks: corporate bond funds and Open Ended Investment Companies. Policy on reserves The charity's reserve5 are represented by its iTJvestsnents and cash balances. The Trustees have reviewed the charity's requirements for unrestricted reserves in the litsht of the main risk's to the organisation. In the opinion of the Trustees, sufficient unrestricted reserves are required 10 meei one year s operaiing cosis in the event of a significant drop in incoming resources and £50,000 is considered io be adequaie for this purpose. The balance of the unrestricted reserves are free reserves and are available to be used to fund projects in accordance with the charity's objects. At 31 March 2024 the unrestricted reserves were £1,500,152 (2023: £1,422,039}. The trustees consider that the reserves held at the year end are above target level. Inveslmcntpolicy and objeclive5 The Trustees are empow'ered to invest and deal w'ith the monies of the charity not immediately required in such a manner as the charity may from lime to time detennine subject to such conditions and consents imposed or required by law. Surplus funds are placed on deposit either with the charity's bankers or with W H Ireland Ltd or invested in UK Government Stocks, corporate bond funds and unit trnsts. Investment returns are governed by the prevailing interest rates and dividend payments. Structure) governance and management Recruilment and appoinlmenl of Irustees No person tnay be appointed as a Trustee unless approved by all the Trustees. At every general meeting one third of the Trustees retire by rotation beinu decided by the length of time in olfice. Subject to the above, University Hospital of South Manchester NHS Foundation Trust (now Manchester University NHS Foundation Trust) may appoint one Trustee. Trustees must be aged 18 years or above and not disqualified by reason of Article l O. l of the charity'5 Articles of Association or in company or charity law. None of the Trustees have aT]y interest in the charity. Trustees are appointed under the provision of Articles 31 to 33 olthe charity'5 Articles of A550ciation. Page 3
Wythenshawe Hospital Transplant Fund Trustees, Report Induclion and Iroining of Iruslees All new Trustees receive a fornial briefing from Ihe Chairnian of their duties and responsibilities and receive various booklets from the Charity Commlssion and Companies House. Truslees are also encouraged to keep themselves abreast of current and proposed developments in charity regulaiion through access to the Charity Cominission website and other relevant sources of infonnation. Major risks and managemenl oflhose risks The Trustees coniinue to review the charity's activities to identify the major risks to which it is exposed and the systems established to mitigate risks are periodically reviewed to ensure that they are operating effectively and still meet the needs of the charity. It has been deterniined that the principal risks and uncertainties are the volatilit), of investments held by the charity and the continued ability to raise volunlary income. The steps taken by the Trustees to mitigate these risks as far as practicable are to maintain and regularly review a diversified portfolio of investments, to maintain sufficient cash reserves and to monitor both investment perfonnance and the level of voluntary income received at each Board meeting. Small companies provision statement This report has been prepared in accordance with the small companies regime under the Companie5 Act 2006. The annual report was approved by the trustee5 of the charity on 1711212024 and signed on its behalf by: D K Cornwall Trustee Page 4
Wythenshawe Hospital Transplant Fund Statement of Trustees, Responsibilities The trustees (who are also the directors of Wythensham'e Hospital Transplant Fund for the purposes of company law) are responsible for preparing the twstees, report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepied Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in ihe UK and Republic of Ireland" Company laTh' requires the trustees to prepare financial statements for each financial year. Under coTnpany law the trustees must not approve the financial statements unless they are satisfied that they give a te and fair view of the state of affairs of the charitable company and of the incoming resources and application of resource5, including its income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required io: select suitable accounting policies and apply them consistently- observe the methods and principles in the Charities SORP; make judgements and estimates that are reasonable and prudent; state whether applicable accounting standards. comprising FRS I O? have been followed, subject to any material departures disclosed and explained in the financial statements- and prepare the financial sthiements on the going concern basis unless it is inappropriate to presume that the charithble company will continue in business. The trustees are responsible for keeping proper accounting records that can disclose M'ith reasoT]able accuracy at any time the financial position of the charitable company and enable them to ensure that the financial 5tatement5 comply with the Companies Act 2006. They are also responsible for Safeguarding the assets of the charitable company and hence for taking reasonable Steps for the prevention and detection of fraud and other irregularities. The trustees are responsible for the maintenance and integrity of the corporate and financial infomation included on the charitable company's website. Legislation governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. Approv the trustees of the charity on .1711212024 and signed on its behalf by: D K Cornwall Trustee Page 5
Wythenshawe Hospital Transplant Fund Independent Examiner's Report to the trustees of W)'thenshawe Hospital Transplant Fund {'the Company,) I report to the charity trnstees on my examination of the accounts of the Company for the year ended 31 March 2024. Responsibilities and basis of report As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act,). Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 {'the ?01 l Act,). In carying out my examination I have followed the Directions given by the Charity Commission under section 145(5Mb} of the 2011 Act. Independenl examiner's statement I have completed my examination. I confTh thal no matters have come to my attention in connection with the examination giving me cause to believe: accounting records were not kept in Spect of Wythenshawe Hospital Transplant Fund as required by section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view. which is not a matter considered as part of an independent examination- or 4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by chariiies [applicable to charities preparing their accounts in accordance with the Financial Reponing Siandard applicable in the UK and Republic of Ireland (FRS 102)]. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper undersLqnding of the accounts to be reached. M.f. Helen Binns FCA Chartered Accountant Beever and Struthers One Express l George Leigh Street Manchester M5 4DL Date..17th December 2024 Page 6
Wythenshawe Hospital Transplant Fund Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses) Unrestrieted funds Restricted funds Total 2024 Note Ineome and Endowments from: Donations and legacies Other trading activities Investment incotne 77,061 54,495 29,505 10,000 87,061 54,495 29,505 Total income 161.061 10,000 171,061 Expendilure on: Raising funds Chariiable activities (17,940) (98,2) l} (17,940) (113.187) (14,956) Total expenditure Gainsllosses on investment assets (116.171} 33,223 (14,956) (131.127) 33,223 Net incomel(expenditure) 78,113 (4,956) 73,157 Net movement in funds 78,113 (4,956) 73,157 Reconciliation of funds Total funds brought forward 1,422.OJ9 13,354 1,435,393 Total funds carried forward 18 1,500,152 8,398 1,508,550 The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements. Page 7
Wythenshawe Hospital Transplant Fund Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses) Unrestrieted funds Restricted funds Total 2023 Note Ineome and Endowments from: Donations and legacies Other trading activities Investment incotne 101,230 30,213 24,530 101,230 30,213 24,530 Total income 155.973 155,973 Expendilure on: Raising funds Chariiable activities (8.969) (10,88i} (8,969) (14,545) (3,660) Total expenditure Gainsllosses on investment assets (19,854} (38,264) (3,660) (23,514) (38,264) Net incomel(expenditure) 97,855 (3,660) 94,195 Net movement in funds 97,855 (3,660) 94,195 Reconciliation of funds Total funds brought forward 1,324.184 17,014 1,341,198 Total funds carried forward 18 1,42?,039 13,354 1,4J5,393 All of the charity's activitie5 derive from continuing operdtion5 during the above two periods. The funds breakdown for 2023 is shown in note 18. The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements. Page 8
Wythenshawe Hospital Transplant Fund (Registration number: 2977135) Balance Sheet as at 31 March 2024 2024 2023 Note Fixed assets Tangible assets 12 818 Current assets Stocks Debtors 13 14 15 16 200 200 178 520,355 923,797 Investtnents Cash at bank and in hand 553,491 964.445 ,518.327 1,444,530 Credilors: Amounts falling due within one year 17 (10,595) (9,137) Net eurrent assets 1,507,732 1,4J5,393 Net assets ,508,550 1,435,393 Funds of the charity: Restricted income funds Restricted funds 8,398 13,354 Unrestricted income funds Unrestricted funds 1,500,152 1,422,039 Total funds 18 ,508,550 1,435,393 For the financial year ending 31 March 2024 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors, responsibilities: The trusteesldirectors have not required the charity to obtain an audit of its accounts for the year in question in accordance with Section 476- and The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the prepardtion of accounts. The financial statements on pages 7 to 20 were approved by the trustees, and authorised for issue on and sioned ehalf by: 1711212024 D K Cornw'all Trustee The notes on pages 10 to 20 fom) an iniegrdl part of these financial slatements. Page 9
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 I Charity stalus The charity is a private company limited by guarantee. incorporated in England and Wales. and consequently does not have share capital. Each of the trustees is liable to contribute an amount not exceeding £ I towards the a55et5 of the charity in the event of liquidation. The address of its regis(ered office is: The Transplant Fund Office Transplant Centre Wirthenshawe Hospital Manchester M23 9LT 2 Accounting policies Summary of significant accounting policies and key accounting estimates The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented. unless othenvise slated. Statement of eomplianee The financial statements have been prepared in accordance with Accounting and Reporting by Charities.. Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. Basis of preparation WythenSha'e Hospital Transplant Fund tneets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unle55 Otherwise stated in the relevant accounting policy note5. The financial statements are prepared in sterling, which is the functional currency of the entity. Going eoncern The trustees consider that there are no material uncertainties about the charit) s ability to continue as a going concern nor any significant areas of uncertainty that affect the carri'ing value of assets held by the charity. Page 10
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 Critical accounting judgements and key sources of estimation uncert2inty The preparation of the financial statements in conforniity with FRS 102 requires the use of certain critical accounting estimates. It can also require the Trustees to exercise their judgement in the process of applying the charity's accounting policies. The charity is not considered to have any critical accounting estimates or judgements at this time. Income and endoiTrment5 All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably. Donations and legacies Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation 15 subject to conditions that require a level of performance by the charity before the charity Is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those condition5 15 wholly within the control of the charity and it 15 probable that these conditions will be fulfilled in the reporting period. Legacy gifts are recognised on a case by case basi5 folloiving the grant of probate when the administrator/executor for ihe estate has communicaied in writing boih ihe amount and settlement date. In the event that the gift is in the forn) of an asset other ihan cash or a financial asset traded on a recognised stock exchange, recognition is subject to the value of the gift being reliably measurable with a detsree of reasonable accuracy and the title to the asset having been transferred to the charity. Grants receivable Grants are recognised when the charity has an entitlemeni to the funds and any conditions linked to the grants have been met. Where perfomiance condilions are attached to ihe grant and are yet to be met, the income is recognised as a liability and included on the balance sheet as deferred income to be released. Investmenl income Dividends are recognised once the dividend has been declared and notification has been received of the dividend due. Expenditure All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliablv. All costs are allocated to the appllcable expenditure heading that aggregate similar costs (o that calegory. Where costs cannoi be directly attributed to particular headii)gs they have been allocated on a basis consistent with the use of resources, with centrdl staff costs allocated on the basis of time spent, and deprecialion charges allocated on the portion of the asset's use. Other support costs are allocated based on the spread of staff cosls. Raisingfunds These are costs incurred in attracting voluntary income, the management of inveslments and those incurred in trading activities that raise funds. Page I
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 Charilable activilies Chariiable expenditure comprises those costs incurred by the charity in Ihe delivery of lis activlties and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. Taxation The charity is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act 201 O and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received '1th1n categories covered by Chapter 3 Part I I of the Corporation Tax Act 201 O or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes. Tangible fixed assets Individual fixed assets costing £0.00 or more are initially recorded at cost, less any subsequent accumulated depreciation and subsequent accumulated impairnient losse5. Depreciation and amortisation Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows- Asset class Computer equipment Depreeiation method and rate ?O/o Straight line Current a55et investments Current asset investments are included at the lower of cosi and net a]isable value / market value. Stock Stock is valued at ihe lower of cost and esiimated selling price less costs to complete and sell, after due regard for obsolete and slow moving stocks. Cosi is deiemiined using the first-in, first-oui (FIFO). Trade debtors Trade debtors are amounts due from customers for merchandise sold or services perfonned in the ordinary course of business. Trade debtors are recognised iniliall). at the trdnsaction price. They are subsequently measured at amortised cost using the effective interest method: less provision for impainnent. A provision for the impairnient of trade debtors is established when there is objective evidence that the charity will not be able to collect all amounts due according to the original tenns of the receivables. Cash and eash equivalents Cash and cash equivalents comprise cash on hand and call deposits: and other short-terrn highly liquid investments that are readily convertible to a knO.n amount of cash and are subject to an insignificant risk of change in value. Page 12
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 Fund strueture Unrestricted income funds are general funds that are available for use at the trustees discretion in furtherance of the objectives of the charity. Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose. Financial inslruments Classificlllion Financial assets and fLnancial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument. Financial liabilities and equity instruments are classifled according to the substance of the contractual arrangements entered into. An equity instrument 15 any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities. Recognition and measuremenl All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at lair value thTOU( .h profit OT loss, which are initially measured at fair value (which is nornially the transaction price excluding transaction costs). unless the arranuemeT]t constitutes a financing transaction. If an arranuement constitutes a financinu travjsaction. the financial asset or fLnancial liability is measured at the present value of the future pa)Tnents discounted at a market rate of interest for a similar debt instrument. Financial assets and liabilities are only offset in the statement of financial position when. and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and seitle the liability simultaneously. Financial assets are derecognised when and only when a) the contractual rights to the cash floitys from the financial asset expire or are settled. b) the charity transfers to anoiher party substhntially all of the risks and rewards of ownership of the financial asset, or c) the chariry, despite having relained some, bui not all, significant risks and rewards of ownership. has transferred control of the asset lo another party. Financial liabilities are derecognised only when the obligation specified in the contract is discharged: cancelled or expires. Page 13
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 3 Income from donations and legacies Unrestrieted funds General Restricted funds Total 2024 Donations and legacies. Donations from companies, trusts and similar proceeds Donations from individuals Legacies In memoriam Grants, including capital grants. Grants from companies 2,465 52,013 5,219 17,364 2,465 52,013 5,219 17,364 10,000 10,000 77.061 10,000 87,061 Unrestricted funds General Total 2023 Donations and legacies; Donations from individuals Legacies In memoriam 43,627 35,226 22,377 43,627 35,226 22,377 101.230 101,230 4 Income from other trading activitie5 Unrestrieted funds General Total 2024 Total 2023 Trading income; Income from sales of n]erchandi5e Fundraising events 972 53,523 972 53,523 1,949 28,264 54,495 54,495 30,213 Page 14
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 5 Inveslment income Unrestrieted funds General Total 2024 Total 2023 Interest receivable and similar income; Interest receivable on bank deposits Oiher investment income 13,185 16,320 13,185 2,459 22,071 29.505 29,505 24,530 6 Expenditure on raising funds a) Costs of trading aetivities Unreslrieted runds General Total 2024 Total 2023 Fundraising trading costs; Fundraising Costs of goods sold 7.719 2.622 7,719 2,622 2,492 10,341 10,341 2,492 Page 15
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 b) Inveslment management costs Unrestrieted funds General Total 2024 Total 2023 Interest payable; Other interest payable Finance charges; Bank charges Other investment management cosls; Amounts payable to inves(ment managers 64 679 679 227 6.856 6,856 6,250 7.599 7,599 6,477 7 Expenditure on charitable activities Unrestrieted funds General Restricted funds Total 2024 Medical supplies / equipment Other charitable donation5 Administration and other costs Staff costs 42,122 24,407 19,655 12,047 3,666 11,008 282 45,788 35,415 19,937 12,047 14,956 113,187 Unreslrieted funds General Restricted funds Total 2023 Medical supplies / equipment Refurbishment costs Other charitable donations Administration and other costs Staff costs 31.217 (89.719) 33.998 13.020 31,217 (89,719) 37,658 13,020 3,660 10,885 3,660 14,545 Page 16
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 8 Net incomingloutgoing resources Net incoming resources for the year include: 2024 2023 Depreciation of fixed assets Finance charges payable Independent Examiners Fee 205 679 2.500 227 2,340 9 Trustees remuneration and expen5e5 No trustees, nor any persons connected with them. have received any remuneration from the charity during the year. No trustees have received any reimbursed expenses or any other benefits from the charity during the year. 10 Staff costs The aggregate payroll costs were as follows: 2024 2023 Staff costs during the year were: Wages and salaries Pension costs 11,468 579 21,074 1,295 12,047 22,369 The monthly average number of persons (including senior management / leadership team} employed by the charity during the year expressed as full time equivalents was as follows: 2024 2023 Administrative Staff No employee received emoluments of more than £60.000 during the year. I l Taxatio The charity is a registered charity and is therefore exempt from taxation. Page 17
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 12 Tangible fixed assets Computer equipment Total Cost Additions 1,023 1,023 At 31 March 2024 1,023 1,023 Depreciation Charge for the year 205 205 At 31 March 2024 205 205 Net book value At 31 March 2024 818 818 13 Stock 2024 2023 Stocks 200 200 14 Debtors 2024 2023 Prepayments Other debtors 177 178 IS Current asset investments 2024 2023 Listed other shares 553,491 520,J55 16 Cash and cash equivalents 2024 2023 Cash at bank 964,445 923.797 Page 18
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 17 Creditors: amounts falling due within one vear 2024 2023 Other taxation and social security Accruals 628 9,967 545 8,592 10,595 18 Funds Other recognised gains/(losses) Balanee at 31 March 2024 Balance at I April 2023 Incoming resources Resources expended Unrestricted funds General 1,422,0)9 161,061 (116,171) 33,223 1,500,152 Restricted funds 10.000 (14,956) 8,398 Total funds 1,435,393 171.061 (131.127) 33,223 1,508,550 Other recognised gains/(losses) Balance at 31 March 2023 Balance at I April 2022 Incoming resource5 Resources expended Unrestricted funds General 1.324.184 155.973 (19,854) (38,264) 1,422,039 Restricted funds 17,014 {3,660) 13,354 Total funds 1.341,198 155.973 (23,514) (J8,264) 1,435,393 The specific purposes for which the funds are to be applied are as follows: The restricted income funds comprise amounts given by donors who indicate thai their donations are to be spent on specific iiems to be used, or projecis io be carried out. ai Wythenshaii¥e Hospithl to further the objects of the charity. The balance at the year end can be split beiween equipment for hearts £424 {2023'. £4,090), expenditure for the bungalows £7.641 (2023.. £7,92J), educalional grant £3J2 (2023: £1.340) Page 19
Wythenshawe Hospital Transplant Fund Notes to the Financial Statements for the Year Ended 31 March 2024 19 Analysis of net assets behveen funds Unrestrieted funds General Total funds at 31 March 2024 Restricted funds Tangible fixed assets Current assets Current liabilities 818 1,509,929 (10,595) 818 1,518,327 (10,595) 8,398 Total net assets 1,500.152 8,398 1,508,550 Unreslrieted funds General Total funds at 31 March 2023 Restricted funds Current assets Current liabilities 1,4Jl,176 (9,137} 13,354 1,444,530 (9,137) Total net assets 1,422,039 13,354 1,435,393 20 Related party transactions There were no related party transactions in the year. Page 20